Editas Medicine, Inc. - Common Stock (NQ:EDIT)
2.880
+0.070
(+2.49%)
Streaming Delayed Price
Updated: 11:28 AM EDT, Aug 11, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 457,454 |
| Open | 2.840 |
| Bid (Size) | 2.880 (500) |
| Ask (Size) | 2.890 (2,100) |
| Prev. Close | 2.810 |
| Today's Range | 2.830 - 2.940 |
| 52wk Range | 1.660 - 4.537 |
| Shares Outstanding | 81,632,619 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Editas Medicine Announces Proposed Public Offering
May 26, 2026
Is Editas Medicine Going to $0? ↗
March 17, 2026
Editas Medicine to Participate in Upcoming Investor Conferences
February 23, 2026
Editas (EDIT) Q2 2024 Earnings Call Transcript ↗
November 27, 2025
Frequently Asked Questions
Is Editas Medicine, Inc. - Common Stock publicly traded?
Yes, Editas Medicine, Inc. - Common Stock is publicly traded.
What exchange does Editas Medicine, Inc. - Common Stock trade on?
Editas Medicine, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Editas Medicine, Inc. - Common Stock?
The ticker symbol for Editas Medicine, Inc. - Common Stock is EDIT on the Nasdaq Stock Market
What is the current price of Editas Medicine, Inc. - Common Stock?
The current price of Editas Medicine, Inc. - Common Stock is 2.880
When was Editas Medicine, Inc. - Common Stock last traded?
The last trade of Editas Medicine, Inc. - Common Stock was at 08/11/26 11:28 AM ET
What is the market capitalization of Editas Medicine, Inc. - Common Stock?
The market capitalization of Editas Medicine, Inc. - Common Stock is 235.10M
How many shares of Editas Medicine, Inc. - Common Stock are outstanding?
Editas Medicine, Inc. - Common Stock has 235M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube